4
Changes in Ownership
Lantern Pharma Inc. Filed Acc 0001493152-25-014614
Options or other derivatives
- Director acquired 12,335 shares (grant or award)
- Director returned 12,335 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
KEYSER D JEFFREY · Director
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-15 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −9,135 | 0 | D |
| 2020-06-15 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +9,135 | 9,135 | D |
| 2021-11-04 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −3,200 | 0 | D |
| 2021-11-04 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +3,200 | 3,200 | D |
Loading xslF345X05/ownership.xml…